眼科人工智慧市場規模、佔有率和成長分析：按技術/演算法、臨床適應症、應用領域、最終用戶和地區分類－2026-2033年產業預測

2024 年全球眼科領域人工智慧市場價值 20 億美元，預計將從 2025 年的 25 億美元成長到 2033 年的 149 億美元，在預測期（2026-2033 年）內複合年成長率為 25.0%。

眼科人工智慧市場的主要驅動力是快速、準確地檢測威脅視力的疾病的迫切需求，這不僅改變了治療流程，也吸引了科技公司和醫療設備製造商的投資。該市場涵蓋用於糖尿病視網膜病變篩檢、青光眼分析、老齡化黃斑部病變檢測以及增強型遠距眼科平台的軟體解決方案，旨在應對視力喪失帶來的重大社會和經濟影響。市場格局正從早期學術演算法轉向整合到篩檢程序中的先進雲端系統，並獲得監管部門的核准。推動成長的關鍵在於可擴展的部署，以應對日益成長的疾病負擔和醫療成本壓力，從而推動對自動化篩檢流程的需求。影像品質的提升和常規的雲端整合能夠實現更有效率的診斷，刺激醫療系統和保險公司對人工智慧驅動解決方案的投資，並為醫療服務提供者和創新夥伴關係關係創造機會。

全球眼科人工智慧市場促進因素

全球眼科人工智慧市場的發展主要得益於深度學習模型和影像處理技術的顯著進步，這些進步顯著提升了視網膜疾病檢測的準確性和可靠性。這些改進使人工智慧工具能夠更早、更精準地識別疾病的細微徵兆，從而增強臨床醫生的信心，並加速人工智慧在臨床工作流程中的應用。醫院、診所和醫療設備製造商為最佳化病患治療效果所採取的措施也進一步推動了這項需求。演算法的日益複雜化為篩檢、診斷和監測等領域的更廣泛應用鋪平了道路，從而拓展了產品系列併提升了市場關注度。隨著這些演算法效能的不斷提高，相關人員越來越願意投資於部署和商業化，這將進一步加速市場成長。

全球眼科人工智慧市場面臨的限制因素

對患者資料隱私和高度敏感的眼科影像安全性的擔憂，給全球眼科人工智慧市場帶來了重大挑戰。這些問題可能導致人們抵制資料共用和人工智慧系統的部署，最終阻礙產品開發和臨床檢驗。醫療機構和設施通常制定了嚴格的管治政策，這會使資料存取變得複雜，並增加供應商滿足合規要求所需的資源。此外，對安全漏洞的擔憂會影響採購決策，並阻礙機構間的合作。所有這些因素都會減緩人工智慧解決方案在日常臨床實踐中的應用，從而限制市場的潛在成長。

眼科人工智慧市場的全球趨勢

全球眼科人工智慧市場正呈現出多模態影像融合的顯著趨勢，這主要得益於技術進步對診斷流程的提升。這種融合能夠無縫整合來自不同影像技術（例如眼底照相和光學相干斷層掃描 (OCT)）的輸出結果，從而改善臨床醫生的決策並減少觀察的差異性。供應商正日益致力於開發可互通的軟體，以標準化影像格式和報告，最佳化轉診流程，並實現有效的疾病長期管理。這一趨勢不僅有助於改善患者表現型分析和加速臨床檢驗，還有助於產品差異化，並表明多模態相容性對於眼科領域的長期臨床成功至關重要。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球眼科領域人工智慧市場規模：按技術/演算法分類

• 深度學習與神經網路
• 自然語言處理（NLP）
• 機器學習（ML）

全球眼科人工智慧市場規模：依臨床適應症分類

• 糖尿病視網膜病變篩檢
• 青光眼檢測和監測
• 老齡化黃斑部病變（AMD）
• 白內障和屈光不正分析

全球眼科人工智慧市場規模：按應用領域分類

• 醫學影像自動化
• 預測分析和患者管理
• 機器人輔助手術

全球眼科領域人工智慧市場規模：按最終用戶分類

• 專科眼科醫院
• 診斷和影像中心
• 學術研究機構

全球眼科領域人工智慧市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要企業2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要企業的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要企業簡介

• Google Health（DeepMind）
• Microsoft（Healthcare AI）
• IBM Watson Health
• Roche（Genentech）
• ZEISS Medical Technology
• Topcon Corporation
• IDx Technologies（Digital Diagnostics）
• Eyenuk Inc.
• Retina-AI Health
• Visulytix
• Airdoc
• NIDEK Co., Ltd.
• Optomed
• DeepEye
• VUNO Inc.
• Lunit
• Artelus
• Remidio
• Orbis International（Cybersight）
• Thirona

結論與建議

Global Ai In Ophthalmology Market size was valued at USD 2.0 Billion in 2024 and is poised to grow from USD 2.5 Billion in 2025 to USD 14.9 Billion by 2033, growing at a CAGR of 25.0% during the forecast period (2026-2033).

The AI in ophthalmology market is primarily driven by the critical need for prompt and precise detection of sight-threatening conditions, significantly transforming care pathways and attracting investments from tech companies and medical device manufacturers. This market incorporates software solutions for diabetic retinopathy screening, glaucoma analysis, macular degeneration detection, and enhanced teleophthalmology platforms, addressing the substantial societal and economic impact of vision loss. The landscape has transitioned from early academic algorithms to advanced cloud-enabled systems integrated into screening programs, bolstered by regulatory approvals. The impetus for growth lies in scalable deployments responding to increasing disease burdens and healthcare cost pressures, leading to greater demand for automated screening processes. Enhanced imaging quality and routine cloud integration enable more efficient diagnostics, encouraging health systems and payers to invest in AI-driven solutions and creating opportunities for providers and innovative partnerships.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ai In Ophthalmology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ai In Ophthalmology Market Segments Analysis

Global ai in ophthalmology market is segmented by technology/algorithm, clinical indication, application area, end-user and region. Based on technology/algorithm, the market is segmented into Deep Learning & Neural Networks, Natural Language Processing (NLP) and Machine Learning (ML). Based on clinical indication, the market is segmented into Diabetic Retinopathy Screening, Glaucoma Detection & Monitoring, Age-Related Macular Degeneration (AMD) and Cataract & Refractive Error Analysis. Based on application area, the market is segmented into Automated Image Diagnosis, Predictive Analytics & Patient Management and Robotic-assisted Surgery. Based on end-user, the market is segmented into Specialized Eye Hospitals, Diagnostic & Imaging Centers and Academic Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ai In Ophthalmology Market

The global AI in ophthalmology market is propelled by significant advancements in deep learning models and image processing techniques that enhance the accuracy and reliability of retinal disease detection. These improvements allow AI tools to recognize subtle indicators of conditions earlier and with greater precision, thereby boosting clinician confidence and fostering the incorporation of AI into clinical workflows. This demand is further supported by hospitals, clinics, and device manufacturers looking to optimize patient outcomes. Enhanced algorithms also pave the way for a wider array of applications in screening, diagnosis, and monitoring, consequently expanding product portfolios and attracting greater market interest. As the performance of these algorithms continues to improve, stakeholders are increasingly inclined to invest in their implementation and commercialization, further accelerating market growth.

Restraints in the Global Ai In Ophthalmology Market

Concerns surrounding patient data privacy and the security of sensitive ophthalmic images present significant challenges for the Global AI in Ophthalmology market. These issues can lead to resistance in sharing datasets and adopting AI systems, ultimately hindering product development and clinical validation. Healthcare providers and institutions often implement strict governance policies, which can complicate access to data and increase the resources required for vendors to achieve compliance. Additionally, fears of security breaches may impact procurement choices and hinder collaboration between institutions, all of which contributes to a slower adoption of AI solutions in everyday clinical practice, thereby limiting potential market expansion.

Market Trends of the Global Ai In Ophthalmology Market

The global AI in ophthalmology market is witnessing a significant trend towards multimodal imaging integration, driven by technological advancements that enhance diagnostic processes. This integration facilitates the seamless combination of outputs from diverse imaging techniques such as fundus photography and OCT, leading to improved clinician decision-making and reduced interpretation variability. Vendors are increasingly focusing on the development of interoperable software that standardizes imaging formats and reporting, thereby optimizing referral workflows and enabling effective longitudinal disease management. This trend not only aids in enriched patient phenotyping and accelerates clinical validation but also enhances product differentiation, establishing multimodal compatibility as critical for long-term clinical success in ophthalmology.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global AI in Ophthalmology Market Size by Technology/Algorithm & CAGR (2026-2033)

• Market Overview
• Deep Learning & Neural Networks
• Natural Language Processing (NLP)
• Machine Learning (ML)

Global AI in Ophthalmology Market Size by Clinical Indication & CAGR (2026-2033)

• Market Overview
• Diabetic Retinopathy Screening
• Glaucoma Detection & Monitoring
• Age-Related Macular Degeneration (AMD)
• Cataract & Refractive Error Analysis

Global AI in Ophthalmology Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Automated Image Diagnosis
• Predictive Analytics & Patient Management
• Robotic-assisted Surgery

Global AI in Ophthalmology Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Specialized Eye Hospitals
• Diagnostic & Imaging Centers
• Academic Research Institutes

Global AI in Ophthalmology Market Size & CAGR (2026-2033)

• North America (Technology/Algorithm, Clinical Indication, Application Area, End-User)
  • US
  • Canada
• Europe (Technology/Algorithm, Clinical Indication, Application Area, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology/Algorithm, Clinical Indication, Application Area, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology/Algorithm, Clinical Indication, Application Area, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology/Algorithm, Clinical Indication, Application Area, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Google Health (DeepMind)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsoft (Healthcare AI)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Genentech)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZEISS Medical Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topcon Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDx Technologies (Digital Diagnostics)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyenuk Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Retina-AI Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Visulytix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Airdoc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIDEK Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optomed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeepEye
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VUNO Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lunit
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artelus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Remidio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orbis International (Cybersight)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thirona
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations